# BioVie (BIVI) — Analyst Forecast

BIVI · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bivi/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 1 | 0 | 0 | 1 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Jul 1, 2024 | ThinkEquity | Initiated Coverage | Buy | $3.00 |
| Nov 30, 2023 | Oppenheimer | Maintained | Outperform | $5.00 |
| Aug 22, 2023 | Cantor Fitzgerald | Maintained | Overweight | $11.00 |
| Jul 18, 2023 | Cantor Fitzgerald | Maintained | Overweight | $11.00 |
| May 17, 2023 | Cantor Fitzgerald | Maintained | Overweight | $11.00 |
| May 17, 2023 | Oppenheimer | Maintained | Outperform | $12.00 |

## Frequently Asked Questions

### Is BIVI a buy, sell, or hold?

Analysts covering BioVie currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on BIVI?

On Jul 1, 2024, ThinkEquity initiated coverage of BioVie at Buy with a price target of $3.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).